| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.565 | 0.012 | 0.565 | GABA C receptor rho-3 antagonist | |||
| 0.452 | 0.007 | 0.452 | 5 Hydroxytryptamine uptake stimulant | 0.193 0.166 CHEMBL3542313 | ||
| 0.422 | 0.005 | 0.422 | Glutamate receptor antagonist | |||
| 0.367 | 0.002 | 0.367 | AMPA 2 receptor antagonist | |||
| 0.436 | 0.073 | 0.891 | Cyclophilin D inhibitor | 0.891 0.005 CHEMBL3542313 | CHEMBL3542313 | |
| 0.361 | 0.006 | 0.361 | GABA C receptor agonist | |||
| 0.338 | 0.004 | 0.338 | GABA C receptor antagonist | |||
| 0.388 | 0.09 | 0.388 | Analgesic | |||
| 0.33 | 0.033 | 0.33 | Anticonvulsant | |||
| 0.363 | 0.081 | 0.707 | Antiobesity | 0.707 0.01 CHEMBL3542313 | CHEMBL3542313 | |
| 0.283 | 0.003 | 0.283 | Kainate receptor 5 antagonist | |||
| 0.267 | 0.017 | 0.267 | Succinate dehydrogenase inhibitor | |||
| 0.3 | 0.066 | 0.3 | Aldehyde oxidase inhibitor | |||
| 0.245 | 0.022 | 0.245 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.239 | 0.017 | 0.239 | Cystathionine beta-synthase inhibitor | 0.212 0.022 CHEMBL3542313 | ||
| 0.241 | 0.03 | 0.241 | Heat shock protein 90 alpha antagonist | |||
| 0.276 | 0.069 | 0.276 | Aryl hydrocarbon receptor agonist | |||
| 0.237 | 0.031 | 0.237 | MAO inhibitor | |||
| 0.206 | 0.003 | 0.206 | Kainate receptor 4 antagonist | |||
| 0.205 | 0.008 | 0.205 | Potassium channel activator | |||
| 0.273 | 0.081 | 0.419 | Spasmolytic | 0.419 0.036 CHEMBL3542313 | CHEMBL3542313 | |
| 0.208 | 0.016 | 0.208 | GABA receptor agonist | |||
| 0.326 | 0.138 | 0.408 | 5 Hydroxytryptamine release inhibitor | 0.408 0.073 CHEMBL3542313 | CHEMBL3542313 | |
| 0.343 | 0.159 | 0.343 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.206 | 0.026 | 0.206 | MAP kinase kinase inhibitor | |||
| 0.194 | 0.016 | 0.194 | Potassium channel (Ca-activated) activator | 0.081 0.074 CHEMBL3542313 | ||
| 0.184 | 0.007 | 0.184 | GABA receptor antagonist | |||
| 0.335 | 0.158 | 0.374 | Caspase 9 stimulant | 0.374 0.127 CHEMBL3542313 | CHEMBL3542313 | |
| 0.183 | 0.01 | 0.183 | DOPA decarboxylase inhibitor | |||
| 0.184 | 0.013 | 0.184 | Sphingomyelinase inhibitor | 0.168 0.018 CHEMBL3542313 | ||
| 0.223 | 0.057 | 0.231 | Nitric-oxide synthase stimulant | 0.231 0.048 CHEMBL3542313 | CHEMBL3542313 | |
| 0.173 | 0.007 | 0.173 | GABA A receptor antagonist | |||
| 0.199 | 0.038 | 0.199 | Heat shock protein 90 antagonist | |||
| 0.262 | 0.102 | 0.262 | 12-Lipoxygenase inhibitor | |||
| 0.158 | 0.003 | 0.158 | Kainate receptor 3 antagonist | |||
| 0.189 | 0.036 | 0.189 | GABA C receptor rho-2 antagonist | |||
| 0.157 | 0.006 | 0.157 | Transcription factor AP-1 inhibitor | 0.064 0.038 CHEMBL3542313 | ||
| 0.238 | 0.091 | 0.238 | Cardiotonic | |||
| 0.154 | 0.008 | 0.154 | NMDA receptor agonist | |||
| 0.147 | 0.003 | 0.147 | AMPA receptor agonist | |||
| 0.169 | 0.026 | 0.169 | 5 Hydroxytryptamine 3A agonist | |||
| 0.177 | 0.042 | 0.324 | Alpha-N-acetylglucosaminidase inhibitor | 0.324 0.014 CHEMBL3542313 | CHEMBL3542313 | |
| 0.227 | 0.093 | 0.227 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.158 | 0.024 | 0.239 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.239 0.011 CHEMBL3542313 | CHEMBL3542313 | |
| 0.152 | 0.019 | 0.152 | Electrolyte absorption antagonist | |||
| 0.15 | 0.017 | 0.15 | Glutamate receptor agonist | |||
| 0.137 | 0.007 | 0.137 | AMPA receptor antagonist | |||
| 0.213 | 0.082 | 0.213 | RNA-directed DNA polymerase inhibitor | 0.19 0.115 CHEMBL3542313 | ||
| 0.158 | 0.028 | 0.158 | Carbonic anhydrase XV inhibitor | |||
| 0.182 | 0.052 | 0.182 | Arachidonic acid antagonist | |||
| 0.146 | 0.018 | 0.146 | ABCA1 expression enhancer | |||
| 0.147 | 0.021 | 0.147 | Acetylcholine M3 receptor agonist | |||
| 0.159 | 0.034 | 0.159 | MAO B inhibitor | |||
| 0.155 | 0.031 | 0.155 | Interleukin 8 antagonist | |||
| 0.128 | 0.004 | 0.128 | Glutamate (mGluR7) antagonist | |||
| 0.171 | 0.048 | 0.184 | Mannose-6-phosphate isomerase inhibitor | 0.184 0.04 CHEMBL3542313 | CHEMBL3542313 | |
| 0.128 | 0.007 | 0.128 | NMDA receptor glycine site agonist | |||
| 0.124 | 0.003 | 0.124 | Potassium channel (Inward rectifier) activator | 0.068 0.013 CHEMBL3542313 | ||
| 0.177 | 0.057 | 0.177 | Death-associated protein kinase 2 inhibitor | |||
| 0.154 | 0.034 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.155 0.033 CHEMBL3542313 | CHEMBL3542313 | |
| 0.198 | 0.079 | 0.209 | Neurotrophic factor enhancer | 0.209 0.068 CHEMBL3542313 | CHEMBL3542313 | |
| 0.122 | 0.003 | 0.122 | Potassium channel (ATP-sensitive) activator | 0.065 0.012 CHEMBL3542313 | ||
| 0.139 | 0.021 | 0.139 | MAP kinase kinase 1 inhibitor | |||
| 0.12 | 0.004 | 0.12 | AMPA 4 receptor antagonist | |||
| 0.126 | 0.015 | 0.126 | Potassium channel large-conductance Ca-activated activator | 0.064 0.052 CHEMBL3542313 | ||
| 0.142 | 0.032 | 0.142 | Carbonic anhydrase III inhibitor | 0.122 0.043 CHEMBL3542313 | ||
| 0.138 | 0.029 | 0.138 | Creatine kinase inhibitor | |||
| 0.117 | 0.008 | 0.117 | Dopamine D5 antagonist | |||
| 0.11 | 0.004 | 0.11 | Cholesterol esterase inhibitor | 0.049 0.031 CHEMBL3542313 | ||
| 0.134 | 0.029 | 0.134 | NMDA receptor antagonist | |||
| 0.172 | 0.068 | 0.172 | Peroxidase inhibitor | |||
| 0.144 | 0.043 | 0.144 | MAO A inhibitor | |||
| 0.173 | 0.072 | 0.173 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.122 | 0.022 | 0.122 | Bromodomain-containing protein 2 inhibitor | |||
| 0.112 | 0.015 | 0.112 | Glycine receptor agonist | 0.1 0.021 CHEMBL3542313 | ||
| 0.104 | 0.009 | 0.104 | Glutamate (mGluR6) antagonist | |||
| 0.117 | 0.023 | 0.117 | HIV-1 reverse transcriptase inhibitor | |||
| 0.138 | 0.045 | 0.138 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.097 | 0.005 | 0.097 | Glutamate (mGluR group III) antagonist | |||
| 0.121 | 0.029 | 0.121 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.094 | 0.003 | 0.094 | Kainate receptor agonist | 0.039 0.036 CHEMBL3542313 | ||
| 0.128 | 0.038 | 0.341 | UDP-glucose 4-epimerase inhibitor | 0.341 0.008 CHEMBL3542313 | CHEMBL3542313 | |
| 0.156 | 0.066 | 0.332 | NOS3 expression enhancer | 0.332 0.014 CHEMBL3542313 | CHEMBL3542313 | |
| 0.125 | 0.036 | 0.125 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.258 | 0.17 | 0.614 | Antibacterial | 0.614 0.017 CHEMBL3542313 | CHEMBL3542313 | |
| 0.111 | 0.024 | 0.131 | Glycine receptor antagonist | 0.131 0.013 CHEMBL3542313 | CHEMBL3542313 | |
| 0.18 | 0.093 | 0.18 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.117 | 0.03 | 0.236 | NADH dehydrogenase inhibitor | 0.236 0.008 CHEMBL3542313 | CHEMBL3542313 | |
| 0.122 | 0.038 | 0.122 | Anabolic | |||
| 0.117 | 0.036 | 0.117 | Estrogen receptor beta antagonist | |||
| 0.177 | 0.095 | 0.177 | Pyruvate kinase inhibitor | |||
| 0.099 | 0.018 | 0.099 | Vanilloid 4 agonist | |||
| 0.086 | 0.005 | 0.086 | GABA uptake inhibitor | |||
| 0.092 | 0.012 | 0.131 | Factor IXa inhibitor | 0.131 0.005 CHEMBL3542313 | CHEMBL3542313 | |
| 0.247 | 0.167 | 0.247 | 15-Lipoxygenase inhibitor | |||
| 0.092 | 0.014 | 0.092 | Heat shock protein 90 beta antagonist | |||
| 0.084 | 0.006 | 0.084 | Kainate receptor 2 antagonist | |||
| 0.082 | 0.004 | 0.082 | Kynurenine 3 monooxygenase inhibitor | 0.034 0.013 CHEMBL3542313 | ||
| 0.084 | 0.007 | 0.084 | AMPA 1 receptor antagonist | |||
| 0.096 | 0.02 | 0.096 | MAP kinase kinase 10 inhibitor | |||
| 0.083 | 0.008 | 0.083 | CXC chemokine 1 receptor antagonist | |||
| 0.151 | 0.077 | 0.281 | Interferon gamma antagonist | 0.281 0.023 CHEMBL3542313 | CHEMBL3542313 | |
| 0.091 | 0.021 | 0.091 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.195 | 0.126 | 0.195 | 5 Hydroxytryptamine release stimulant | 0.17 0.153 CHEMBL3542313 | ||
| 0.074 | 0.005 | 0.074 | AMPA 3 receptor antagonist | |||
| 0.078 | 0.01 | 0.078 | Kainate receptor antagonist | |||
| 0.099 | 0.031 | 0.099 | D-Ala-D-Ala ligase inhibitor | |||
| 0.094 | 0.027 | 0.094 | Dopamine D1 antagonist | |||
| 0.096 | 0.03 | 0.096 | Estrogen receptor alpha antagonist | |||
| 0.1 | 0.035 | 0.1 | Glutamate (mGluR) antagonist | |||
| 0.098 | 0.033 | 0.098 | NMDA 2 receptor antagonist | |||
| 0.121 | 0.059 | 0.121 | Caspase 3 inhibitor | |||
| 0.076 | 0.014 | 0.076 | NMDA receptor subunit 3B antagonist | |||
| 0.088 | 0.028 | 0.088 | GABA B receptor agonist | |||
| 0.072 | 0.012 | 0.072 | Pregnane X receptor antagonist | |||
| 0.092 | 0.032 | 0.092 | Lipase inhibitor | |||
| 0.089 | 0.031 | 0.089 | Glutamate (mGluR group I) antagonist | |||
| 0.062 | 0.004 | 0.062 | CF transmembrane conductance regulator antagonist | |||
| 0.117 | 0.06 | 0.117 | Estrogen antagonist | |||
| 0.229 | 0.173 | 0.229 | Calcium channel activator | |||
| 0.072 | 0.016 | 0.072 | Glutamate (mGluR5) antagonist | |||
| 0.138 | 0.083 | 0.385 | Hemostatic | 0.385 0.009 CHEMBL3542313 | CHEMBL3542313 | |
| 0.064 | 0.009 | 0.064 | Farnesoid X receptor agonist | |||
| 0.086 | 0.033 | 0.086 | Amidase inhibitor | |||
| 0.106 | 0.054 | 0.106 | GABA C receptor rho-1 antagonist | |||
| 0.137 | 0.085 | 0.137 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.216 | 0.167 | 0.404 | Vasodilator, coronary | 0.404 0.034 CHEMBL3542313 | CHEMBL3542313 | |
| 0.062 | 0.016 | 0.062 | NMDA receptor subunit 3A antagonist | |||
| 0.076 | 0.031 | 0.076 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.135 | 0.09 | 0.135 | Acetylcholine M1 receptor antagonist | |||
| 0.098 | 0.053 | 0.098 | Bile acid receptor antagonist | |||
| 0.052 | 0.008 | 0.052 | Glutamate (mGluR8) antagonist | 0.039 0.018 CHEMBL3542313 | ||
| 0.079 | 0.039 | 0.079 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.105 | 0.065 | 0.105 | Ferrochelatase inhibitor | |||
| 0.077 | 0.039 | 0.077 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.072 | 0.036 | 0.072 | Aryl hydrocarbon receptor antagonist | |||
| 0.062 | 0.028 | 0.062 | 5 Hydroxytryptamine 7 agonist | |||
| 0.041 | 0.007 | 0.041 | Kainate receptor 1 antagonist | |||
| 0.076 | 0.044 | 0.076 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.092 | 0.061 | 0.142 | Uric acid excretion stimulant | 0.142 0.026 CHEMBL3542313 | CHEMBL3542313 | |
| 0.191 | 0.162 | 0.191 | Prostaglandin dehydrogenase inhibitor | |||
| 0.051 | 0.022 | 0.051 | Liver X receptor agonist | |||
| 0.047 | 0.019 | 0.047 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.082 | 0.055 | 0.082 | Carbonic anhydrase VI inhibitor | |||
| 0.066 | 0.04 | 0.066 | 5 Hydroxytryptamine 3 agonist | |||
| 0.089 | 0.062 | 0.173 | Triose-phosphate isomerase inhibitor | 0.173 0.015 CHEMBL3542313 | CHEMBL3542313 | |
| 0.154 | 0.128 | 0.154 | Insulin sensitizer | |||
| 0.065 | 0.039 | 0.065 | Dopamine D4 antagonist | |||
| 0.056 | 0.032 | 0.056 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.073 | 0.048 | 0.073 | Histidine decarboxylase inhibitor | |||
| 0.046 | 0.023 | 0.046 | Liver X receptor alpha agonist | |||
| 0.036 | 0.014 | 0.036 | Glutamate (mGluR3) agonist | |||
| 0.121 | 0.099 | 0.265 | Cell wall synthesis inhibitor | 0.265 0.013 CHEMBL3542313 | CHEMBL3542313 | |
| 0.075 | 0.054 | 0.093 | Carbonic anhydrase XIII inhibitor | 0.093 0.041 CHEMBL3542313 | CHEMBL3542313 | |
| 0.193 | 0.171 | 0.5 | Cholesterol antagonist | 0.5 0.033 CHEMBL3542313 | CHEMBL3542313 | |
| 0.11 | 0.09 | 0.263 | Cyclooxygenase 3 inhibitor | 0.263 0.008 CHEMBL3542313 | CHEMBL3542313 | |
| 0.09 | 0.071 | 0.133 | Xanthine oxidase inhibitor | 0.133 0.041 CHEMBL3542313 | CHEMBL3542313 | |
| 0.075 | 0.056 | 0.075 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.04 | 0.021 | 0.04 | Glutamate (mGluR3) antagonist | |||
| 0.042 | 0.025 | 0.042 | Dopamine D5 agonist | |||
| 0.05 | 0.034 | 0.05 | Bromodomain-containing protein 3 inhibitor | |||
| 0.073 | 0.057 | 0.078 | GABA aminotransferase inhibitor | 0.078 0.049 CHEMBL3542313 | CHEMBL3542313 | |
| 0.062 | 0.048 | 0.062 | Calcium channel P-type blocker | |||
| 0.027 | 0.013 | 0.027 | Glutamate (mGluR1) agonist | |||
| 0.093 | 0.081 | 0.193 | Beta glucuronidase inhibitor | 0.193 0.014 CHEMBL3542313 | CHEMBL3542313 | |
| 0.125 | 0.113 | 0.125 | Pregnane X receptor agonist | |||
| 0.054 | 0.042 | 0.054 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.052 0.045 CHEMBL3542313 | ||
| 0.027 | 0.017 | 0.027 | Thyroid hormone agonist | |||
| 0.057 | 0.047 | 0.057 | Purinergic P2X1 antagonist | |||
| 0.092 | 0.082 | 0.219 | AMP-activated protein kinase stimulant | 0.219 0.009 CHEMBL3542313 | CHEMBL3542313 | |
| 0.049 | 0.039 | 0.049 | 5 Hydroxytryptamine 2 agonist | |||
| 0.027 | 0.017 | 0.112 | Sodium/glucose cotransporter 2 inhibitor | 0.112 0.002 CHEMBL3542313 | CHEMBL3542313 | |
| 0.074 | 0.065 | 0.074 | Acetylcholine nicotinic agonist | |||
| 0.046 | 0.037 | 0.069 | Glucose-6-phosphate isomerase inhibitor | 0.069 0.013 CHEMBL3542313 | CHEMBL3542313 | |
| 0.052 | 0.044 | 0.052 | Sphingosine kinase 2 inhibitor | |||
| 0.015 | 0.008 | 0.015 | Integrin beta6 antagonist | |||
| 0.044 | 0.038 | 0.044 | Glutamate (mGluR group I) agonist | |||
| 0.027 | 0.02 | 0.027 | Uridine phosphorylase inhibitor | |||
| 0.028 | 0.022 | 0.028 | Purinergic P2Y15 antagonist | |||
| 0.149 | 0.144 | 0.149 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.052 | 0.047 | 0.052 | Fatty acid synthase inhibitor | |||
| 0.054 | 0.05 | 0.054 | Androgen agonist | |||
| 0.05 | 0.045 | 0.05 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.037 | 0.033 | 0.117 | Factor XIa inhibitor | 0.117 0.004 CHEMBL3542313 | CHEMBL3542313 | |
| 0.051 | 0.047 | 0.051 | Dihydroorotate oxidase inhibitor | |||
| 0.055 | 0.051 | 0.055 | Acetylcholine M5 receptor antagonist | |||
| 0.023 | 0.019 | 0.023 | NMDA receptor glycine site antagonist | |||
| 0.022 | 0.019 | 0.022 | Epoxide hydrolase 2 inhibitor | |||
| 0.063 | 0.061 | 0.063 | MDM2 inhibitor | |||
| 0.018 | 0.016 | 0.018 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.024 | 0.023 | 0.024 | Thymidine phosphorylase inhibitor | |||
| 0.048 | 0.047 | 0.048 | Acetylcholine M2 receptor agonist | |||
| 0.023 | 0.022 | 0.023 | 5 Hydroxytryptamine 4 agonist | |||
| 0.023 | 0.024 | 0.098 | Sodium/glucose cotransporter inhibitor | 0.098 0.003 CHEMBL3542313 | CHEMBL3542313 | |
| 0.132 | 0.137 | 0.227 | ATPase inhibitor | 0.227 0.021 CHEMBL3542313 | CHEMBL3542313 | |
| 0.019 | 0.024 | 0.024 | Dopamine D1 agonist | 0.024 0.015 CHEMBL3542313 | CHEMBL3542313 | |
| 0.096 | 0.104 | 0.102 | Aldehyde dehydrogenase inhibitor | 0.102 0.095 CHEMBL3542313 | CHEMBL3542313 | |
| 0.007 | 0.018 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 CHEMBL3542313 | CHEMBL3542313 | |
| 0.059 | 0.071 | 0.103 | Na+ K+ transporting ATPase inhibitor | 0.103 0.029 CHEMBL3542313 | CHEMBL3542313 | |
| 0.079 | 0.095 | 0.094 | Glutamate release inhibitor | 0.094 0.054 CHEMBL3542313 | CHEMBL3542313 | |
| 0.104 | 0.127 | 0.213 | Diuretic | 0.213 0.039 CHEMBL3542313 | CHEMBL3542313 | |
| 0.028 | 0.059 | 0.087 | Phosphorylase inhibitor | 0.087 0.015 CHEMBL3542313 | CHEMBL3542313 | |
| 0.044 | 0.079 | 0.128 | Phosphofructokinase-1 inhibitor | 0.128 0.023 CHEMBL3542313 | CHEMBL3542313 | |
| 0.01 | 0.046 | 0.016 | Telomerase stimulant | 0.016 0.015 CHEMBL3542313 | CHEMBL3542313 | |
| 0.068 | 0.111 | 0.08 | Interleukin 5 antagonist | 0.08 0.074 CHEMBL3542313 | CHEMBL3542313 | |
| 0.114 | 0.159 | 0.149 | Anesthetic general | 0.149 0.115 CHEMBL3542313 | CHEMBL3542313 | |
| 0.101 | 0.154 | 0.186 | Hexokinase inhibitor | 0.186 0.044 CHEMBL3542313 | CHEMBL3542313 | |
| 0.016 | 0.07 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 CHEMBL3542313 | CHEMBL3542313 | |
| 0.107 | 0.162 | 0.137 | Psychostimulant | 0.137 0.128 CHEMBL3542313 | CHEMBL3542313 | |
| 0.025 | 0.086 | 0.05 | Aldose reductase inhibitor | 0.05 0.039 CHEMBL3542313 | CHEMBL3542313 | |
| 0.094 | 0.156 | 0.156 | DNA repair enzyme inhibitor | 0.156 0.026 CHEMBL3542313 | CHEMBL3542313 | |
| 0.01 | 0.087 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.01 CHEMBL3542313 | CHEMBL3542313 | |
| 0.017 | 0.097 | 0.035 | Factor XI inhibitor | 0.035 0.021 CHEMBL3542313 | CHEMBL3542313 | |
| 0.081 | 0.162 | 0.144 | Interleukin 4 antagonist | 0.144 0.055 CHEMBL3542313 | CHEMBL3542313 | |
| 0.067 | 0.15 | 0.261 | Amylase inhibitor | 0.261 0.025 CHEMBL3542313 | CHEMBL3542313 | |
| 0.1 | 0.185 | 0.156 | Melanin inhibitor | 0.156 0.074 CHEMBL3542313 | CHEMBL3542313 | |
| 0.108 | 0.194 | 0.275 | Hypolipemic | 0.275 0.057 CHEMBL3542313 | CHEMBL3542313 | |
| 0.022 | 0.112 | 0.053 | Carbonic anhydrase XIV inhibitor | 0.053 0.03 CHEMBL3542313 | CHEMBL3542313 | |
| 0.02 | 0.112 | 0.054 | Mannosidase inhibitor | 0.054 0.021 CHEMBL3542313 | CHEMBL3542313 | |
| 0.137 | 0.232 | 0.261 | DNA synthesis inhibitor | 0.261 0.06 CHEMBL3542313 | CHEMBL3542313 | |
| 0.031 | 0.13 | 0.086 | Heparanase inhibitor | 0.086 0.005 CHEMBL3542313 | CHEMBL3542313 | |
| 0.027 | 0.131 | 0.058 | Alpha-mannosidase inhibitor | 0.058 0.03 CHEMBL3542313 | CHEMBL3542313 | |
| 0.038 | 0.143 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.017 CHEMBL3542313 | CHEMBL3542313 | |
| 0.097 | 0.223 | 0.201 | Non-steroidal antiinflammatory agent | 0.201 0.07 CHEMBL3542313 | CHEMBL3542313 | |
| 0.097 | 0.225 | 0.398 | Immunostimulant | 0.398 0.05 CHEMBL3542313 | CHEMBL3542313 | |
| 0.061 | 0.192 | 0.162 | Toll-Like receptor 4 antagonist | 0.162 0.015 CHEMBL3542313 | CHEMBL3542313 | |
| 0.025 | 0.159 | 0.064 | Nitric oxide donor | 0.064 0.041 CHEMBL3542313 | CHEMBL3542313 | |
| 0.15 | 0.286 | 0.393 | Histamine release inhibitor | 0.393 0.079 CHEMBL3542313 | CHEMBL3542313 | |
| 0.138 | 0.278 | 0.284 | Alpha-glucosidase inhibitor | 0.284 0.168 CHEMBL3542313 | CHEMBL3542313 | |
| 0.064 | 0.245 | 0.113 | Protein kinase stimulant | 0.113 0.1 CHEMBL3542313 | CHEMBL3542313 | |
| 0.106 | 0.292 | 0.388 | Transcription factor NF kappa B inhibitor | 0.388 0.066 CHEMBL3542313 | CHEMBL3542313 | |
| 0.065 | 0.294 | 0.24 | Interleukin agonist | 0.24 0.087 CHEMBL3542313 | CHEMBL3542313 | |
| 0.035 | 0.269 | 0.063 | Lipocortins synthesis agonist | 0.063 0.03 CHEMBL3542313 | CHEMBL3542313 | |
| 0.104 | 0.339 | 0.45 | Antithrombotic | 0.45 0.038 CHEMBL3542313 | CHEMBL3542313 | |
| 0.04 | 0.276 | 0.117 | Multidrug resistance-associated protein 1 inhibitor | 0.117 0.052 CHEMBL3542313 | CHEMBL3542313 | |
| 0.024 | 0.304 | 0.112 | Expectorant | 0.112 0.057 CHEMBL3542313 | CHEMBL3542313 | |
| 0.058 | 0.339 | 0.354 | Platelet adhesion inhibitor | 0.354 0.019 CHEMBL3542313 | CHEMBL3542313 | |
| 0.023 | 0.311 | 0.184 | Topoisomerase I inhibitor | 0.184 0.03 CHEMBL3542313 | CHEMBL3542313 | |
| 0.019 | 0.312 | 0.075 | Glucose-6-phosphate translocase inhibitor | 0.075 0.013 CHEMBL3542313 | CHEMBL3542313 | |
| 0.027 | 0.321 | 0.105 | ATPase (Vacuolar H+) inhibitor | 0.105 0.033 CHEMBL3542313 | CHEMBL3542313 | |
| 0.042 | 0.338 | 0.367 | Anticoagulant | 0.367 0.02 CHEMBL3542313 | CHEMBL3542313 | |
| 0.012 | 0.313 | 0.327 | Selectin antagonist | 0.327 0.004 CHEMBL3542313 | CHEMBL3542313 | |
| 0.09 | 0.399 | 0.146 | CC chemokine 6 receptor antagonist | 0.146 0.029 CHEMBL3542313 | CHEMBL3542313 | |
| 0.097 | 0.438 | 0.367 | Apoptosis antagonist | 0.367 0.049 CHEMBL3542313 | CHEMBL3542313 | |
| 0.068 | 0.421 | 0.595 | Hypoglycemic | 0.595 0.008 CHEMBL3542313 | CHEMBL3542313 | |
| 0.065 | 0.418 | 0.439 | Immunosuppressant | 0.439 0.05 CHEMBL3542313 | CHEMBL3542313 | |
| 0.104 | 0.457 | 0.404 | Interleukin 2 agonist | 0.404 0.026 CHEMBL3542313 | CHEMBL3542313 | |
| 0.037 | 0.432 | 0.256 | Platelet antagonist | 0.256 0.07 CHEMBL3542313 | CHEMBL3542313 | |
| 0.03 | 0.444 | 0.097 | DNA polymerase I inhibitor | 0.097 0.09 CHEMBL3542313 | CHEMBL3542313 | |
| 0.038 | 0.463 | 0.306 | Nitric oxide antagonist | 0.306 0.039 CHEMBL3542313 | CHEMBL3542313 | |
| 0.022 | 0.472 | 0.257 | Thrombolytic | 0.257 0.032 CHEMBL3542313 | CHEMBL3542313 | |
| 0.013 | 0.51 | 0.084 | Topoisomerase II alpha inhibitor | 0.084 0.05 CHEMBL3542313 | CHEMBL3542313 | |
| 0.081 | 0.583 | 0.703 | Antiinflammatory | 0.703 0.03 CHEMBL3542313 | CHEMBL3542313 | |
| 0.082 | 0.587 | 0.38 | Peptidyltransferase inhibitor | 0.38 0.008 CHEMBL3542313 | CHEMBL3542313 | |
| 0.063 | 0.584 | 0.217 | Caspase 3 stimulant | 0.217 0.146 CHEMBL3542313 | CHEMBL3542313 | |
| 0.049 | 0.583 | 0.488 | Immunomodulator | 0.488 0.025 CHEMBL3542313 | CHEMBL3542313 | |
| 0.026 | 0.572 | 0.432 | Antioxidant | 0.432 0.03 CHEMBL3542313 | CHEMBL3542313 | |
| 0.008 | 0.559 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.057 CHEMBL3542313 | CHEMBL3542313 | |
| 0.005 | 0.567 | 0.039 | Protein 30S ribosomal subunit inhibitor | 0.039 0.01 CHEMBL3542313 | CHEMBL3542313 | |
| 0.011 | 0.587 | 0.07 | Antibiotic Aminoglycoside-like | 0.07 0.006 CHEMBL3542313 | CHEMBL3542313 | |
| 0.011 | 0.596 | 0.091 | Cell adhesion molecule inhibitor | 0.091 0.042 CHEMBL3542313 | CHEMBL3542313 | |
| 0.016 | 0.612 | 0.382 | Free radical scavenger | 0.382 0.032 CHEMBL3542313 | CHEMBL3542313 | |
| 0.02 | 0.629 | 0.222 | Vasodilator | 0.222 0.088 CHEMBL3542313 | CHEMBL3542313 | |
| 0.008 | 0.626 | 0.094 | Protein 50S ribosomal subunit inhibitor | 0.094 0.015 CHEMBL3542313 | CHEMBL3542313 | |
| 0.018 | 0.667 | 0.179 | Insulin secretagoues | 0.179 0.049 CHEMBL3542313 | CHEMBL3542313 | |
| 0.004 | 0.678 | 0.113 | Antineoplastic antibiotic | 0.113 0.041 CHEMBL3542313 | CHEMBL3542313 | |
| 0.029 | 0.704 | 0.346 | Hepatoprotectant | 0.346 0.019 CHEMBL3542313 | CHEMBL3542313 | |
| 0.014 | 0.691 | 0.579 | Angiogenesis stimulant | 0.579 0.008 CHEMBL3542313 | CHEMBL3542313 | |
| 0.008 | 0.701 | 0.123 | Topoisomerase II inhibitor | 0.123 0.065 CHEMBL3542313 | CHEMBL3542313 | |
| 0.014 | 0.708 | 0.168 | Cell adhesion inhibitor | 0.168 0.036 CHEMBL3542313 | CHEMBL3542313 | |
| 0.006 | 0.761 | 0.153 | Lipid peroxidase inhibitor | 0.153 0.066 CHEMBL3542313 | CHEMBL3542313 | |
| 0.02 | 0.854 | 0.111 | Transcription factor NF kappa B stimulant | 0.111 0.03 CHEMBL3542313 | CHEMBL3542313 | |
| 0.007 | 0.857 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 CHEMBL3542313 | CHEMBL3542313 | |
| 0.012 | 0.87 | 0.388 | Apoptosis agonist | 0.388 0.119 CHEMBL3542313 | CHEMBL3542313 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |